Sangamo Therapeutics Inc SGMO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/03/24 EDT
0.5558quote price arrow up+0.0338 (+6.4751%)
Volume
1,163,846
52 week range
0.29 - 1.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5558
  • 52 Week High1.67
  • 52 Week High Date07/18/23
  • 52 Week Low0.29
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap115.326M
  • Shares Out207.50M
  • 10 Day Average Volume1.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change2.3

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.5558
  • 52 Week High1.67
  • 52 Week High Date07/18/23
  • 52 Week Low0.29
  • 52 Week Low Date11/13/23
  • Market Cap115.326M
  • Shares Out207.50M
  • 10 Day Average Volume1.14M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change2.3

RATIOS/PROFITABILITY

  • EPS (TTM)-1.46
  • P/E (TTM)-0.38
  • Fwd P/E (NTM)-1.05
  • EBITDA (TTM)-87.527M
  • ROE (TTM)-136.47%
  • Revenue (TTM)176.232M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-146.30%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sangamo Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to...
H. Stewart Parker
Independent Chairman of the Board
Alexander Macrae Ph.D.
President, Chief Executive Officer, Director
Prathyusha Duraibabu CPA
Chief Financial Officer, Senior Vice President
Address
501 Canal Blvd.
Richmond, CA
94084
United States

Top Peers

SYMBOLLASTCHG%CHG
FGEN
FibroGen Inc
1.14+0.01+0.88%
NSTGQ
NanoString Technologies Inc
0.205UNCHUNCH
KPTI
Karyopharm Therapeutics Inc
1.13+0.05+4.63%
AGEN
Agenus Inc
13.07+0.55+4.39%
XERS
Xeris Biopharma Holdings Inc
1.89+0.03+1.61%